N-5 MEDIATED DECISION SUPPORT IN PROSTATE CANCER SCREENING

Wednesday, October 27, 2010: 11:15 AM
Grand Ballroom West (Sheraton Centre Toronto Hotel)
Ronald E. Myers, PhD1, Constantine Daskalakis, DSc1, Elisabeth Kunkel, MD1, James Cocroft, MA1, Jeffrey Riggio, MD1, Mark Capkin, MD2 and Clarence Braddock, MD, MPH3, (1)Thomas Jefferson University, Philadelphia, PA, (2)Albert Einstein Healthcare Network, Philadelphia, PA, (3)Stanford University, Standord, CA

Purpose: This randomized trial was conducted to assess the impact of a mediated decision support intervention on primary care patient prostate cancer screening knowledge, decisional conflict, informed decision making (IDM), and screening. 

Method: Before a routine office visit, 313 male patients eligible for prostate cancer screening completed a baseline telephone survey and received a mailed brochure on prostate cancer screening.  At the visit, participants were randomized to either an enhanced intervention (EI) or a standard intervention (SI) group.  Before meeting with their physician, EI Group men had a nurse-led "decision counseling" session, while SI Group men completed a practice satisfaction survey.  An endpoint survey was administered.  Survey data, encounter audio recordings, and chart audit data were used to assess study outcomes.

Result: Knowledge increased in the EI Group (mean difference of +0.8 on a 10-point scale, p=0.001), but decisional conflict did not change (mean difference of -0.02 on a 4-point scale, p=0.620). The EI Group had higher IDM (rate ratio=1.30, p=0.029) and lower screening (odds ratio=0.67, p=0.102).

Conclusion: Nurse-mediated decision counseling increased participant prostate cancer screening knowledge.  The intervention also influenced informed decision making and screening use.